It is important to recognise that patients prescribed GLP-1 agonists often have underlying conditionssuch as type 2 diabetes, obesity, hypertension, and dyslipidaemiathat independently increase cardiovascular and thrombotic risk
EClinicalMedicine 3(72):102624 Jensen SBK, Srensen V, Sandsdal RM, Lehmann EW, Lundgren JR, Juhl CR et al (2024) Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial
Tips for avoiding a gap in GLP-1 treatment Gaps in treatment can be frustrating, but you can take a few steps to reduce the risk of it happening and lessen the impact on your weight loss
Digestive hormones naturally peak and fall throughout the day, and aligning your injection with your body's natural rhythms can enhance medication effectiveness
Our Aon measurement approach follows each patient in their journey recognizing unique starting points in each population
That way, you can benefit from the wanted effects of your GLP-1 and minimize the unwanted ones